Skip to content

STRONGBRIDGE BIOPHARMA plc

CIK 0001634432

← back to feed
Revenue (TTM)
$34.26M
+41.5% YoY Q2 Aug 2021
Net Income (TTM)
−$45.49M
−278.2% YoY Q2 Aug 2021
EPS Diluted (TTM)
−$0.89
0.0% YoY Q2 Aug 2021
Gross Margin
98.5%
Q2 Aug 2021
Operating Margin
-123.8%
Q2 Aug 2021
Net Margin
-132.8%
Q2 Aug 2021
Free Cash Flow (TTM)
−$64.97M
Q2 Aug 2021
Cash
$63.77M
Q2 Aug 2021
Total Debt
$17.71M
Q2 Aug 2021
Shares Outstanding
67.83M sh
Q2 Aug 2021

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings